$COCP November Hong Kong trials were delayed in October due to the civil unrest and political instability in Hong Kong. Expect Phase 2b study of CC-31244 to begin at any time. Phase 2b study of CC-31244 was to begin early last Q was "delayed a quarter due, in part, to the civil unrest and political instability in Hong Kong." Hong Kong trials starting to kick into high gear again now that the unrest has abated 39 trials started up this past week. centerwatch.com/clinical-tr... So mark31 you are in at the perfect time. Also this quarter "Complete preclinical CC-42344 IND-enabling studies in Q1 2020." Company update on Influenza A/B Program with Merck, CC-42344 IND-enabling studies and Hong Kong trials starting for CC-31244 is expected anytime as we enter the beginning of the 3rd week of January. We got this.